Company Filing History:
1 out of 76 
1 out of 2,077 
1 out of 363 
Years Active: 2008-2010
Title: **Naresh Chadha: Innovator in Protein Kinase Inhibition**
Introduction
Naresh Chadha is a prominent inventor based in Montville, NJ, United States, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, Chadha has focused on the development of compounds that act as inhibitors of protein tyrosine kinases, particularly the c-fms kinase.
Latest Patents
Chadha's latest innovations include a series of patents directed toward c-fms kinase inhibitors. Notably, his inventions are based on compounds of Formula II, which includes particular elements such as A, R, X, Y, and W as defined in the specifications. These compounds, along with their solvates, hydrates, tautomers, and pharmaceutically acceptable salts, are designed to inhibit the activity of protein tyrosine kinases, providing potential treatment options for various diseases linked to kinase activity.
Additionally, another patent from Chadha focuses on various compounds of Formulae I, II, and III, also aimed at inhibiting c-fms kinase. These contributions underscore his commitment to advancing therapeutic research in the field of protein kinases.
Career Highlights
Throughout his career, Naresh Chadha has made valuable strides in pharmaceutical research and development. He has been associated with notable companies such as 3-Dimensional Pharmaceuticals, Inc. and Janssen Pharmaceutica NV, where he has played a crucial role in innovative drug development projects. His expertise in developing kinase inhibitors demonstrates his significant impact on the industry.
Collaborations
In his professional journey, Chadha has had the opportunity to work alongside esteemed colleagues such as Mark R. Player and Nand Baindur. Collaborating with talented professionals has allowed him to enhance his research capabilities and contribute to groundbreaking advancements in biotechnology.
Conclusion
Naresh Chadha's work as an inventor has notably advanced the field of protein kinase inhibition. His innovative compounds and collaborations reflect his dedication to medical research and the improvement of patient outcomes. With three patents to his name, Chadha continues to be a key figure in the biotechnology landscape, paving the way for future innovations in therapeutic treatments.